Literature DB >> 23773951

Is opioid substitution treatment beneficial if injecting behaviour continues?

Linn Gjersing1, Anne Line Bretteville-Jensen.   

Abstract

BACKGROUND: Opioid substitution treatment (OST) is recognised as an effective treatment for opioid dependence. Still, a subgroup of OST users continues to inject drugs. This study examines health risks and criminal activity in a population of needle exchange programme (NEP) participants by comparing those identified as current OST users to (i) those identified as former OST users and (ii) those with no OST experience.
METHODS: This was a semi-annual cross-sectional study conducted from 2002 to 2011. NEP participants were interviewed in Oslo, Norway (n=1760); 341 were identified as current OST users, 356 as former OST users and 1063 had no OST experience. The associations between OST status and health risk and criminal activity were assessed through univariate and multiple logistic regression analyses.
RESULTS: Among NEP participants, those currently in OST had fewer non-fatal overdoses (OR=0.5 [95% CI 0.3, 0.9]) compared to former OST users and those never in OST. Additionally, they were less likely to have injected frequently (OR=0.4 [95% CI 0.3, 06]), to have used heroin daily or almost daily (OR=0.3 [95% CI 0.2, 0.4]), and to have committed theft (OR=0.6 [95% CI 0.4, 1.0]) and engaged in drug dealing (OR=0.7 [95% CI 0.5, 0.9]) in the past month. Overall, there was a high level of polysubstance use and no group differences on this measure.
CONCLUSIONS: NEP participants who are currently in OST have substantially reduced health risks and criminal activity than other NEP participants. The high level of polysubstance use nevertheless poses a public health challenge.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Crime; Drug user; Injecting drug user; Needle-exchange programmes; Opioid substitution treatment; Overdose

Mesh:

Year:  2013        PMID: 23773951     DOI: 10.1016/j.drugalcdep.2013.05.022

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  5 in total

1.  Expanding low-threshold buprenorphine to justice-involved individuals through mobile treatment: Addressing a critical care gap.

Authors:  Noa Krawczyk; Megan Buresh; Michael S Gordon; Thomas R Blue; Michael I Fingerhood; Deborah Agus
Journal:  J Subst Abuse Treat       Date:  2019-05-09

2.  Responding to the opioid and overdose crisis with innovative services: The recovery community center office-based opioid treatment (RCC-OBOT) model.

Authors:  Robert D Ashford; Austin M Brown; Jessica McDaniel; Jenna Neasbitt; Chad Sobora; Robert Riley; Lesley Weinstein; Aaron Laxton; Justin Kunzelman; Kyle Kampman; Brenda Curtis
Journal:  Addict Behav       Date:  2019-06-21       Impact factor: 3.913

Review 3.  The role of prevention strategies in achieving HCV elimination in Canada: what are the remaining challenges?

Authors:  Stine Bordier Høj; Nanor Minoyan; Andreea Adelina Artenie; Jason Grebely; Julie Bruneau
Journal:  Can Liver J       Date:  2018-07-17

Review 4.  A review of buprenorphine diversion and misuse: the current evidence base and experiences from around the world.

Authors:  Michelle R Lofwall; Sharon L Walsh
Journal:  J Addict Med       Date:  2014 Sep-Oct       Impact factor: 3.702

5.  Changes in opiate and stimulant use through 10 years: The role of contextual factors, mental health disorders and psychosocial factors in a prospective SUD treatment cohort study.

Authors:  Grethe Lauritzen; Trond Nordfjærn
Journal:  PLoS One       Date:  2018-01-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.